# A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD)

> **NCT00644358** · PHASE3 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 616 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** vilazodone

## Key facts

- **NCT ID:** NCT00644358
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12-31
- **Primary completion:** 2009-05-31
- **Final completion:** 2009-05-31
- **Target enrollment:** 616 (ACTUAL)
- **Last updated:** 2017-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00644358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00644358, "A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00644358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*